Search

everythinglearnresearchcommunity

for

Search:↓

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

Newly made nicotinamide compounds could potentially treat cancer.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The type 3 IP3 receptor is important for controlling hair loss and growth.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

MK-386 lowers DHT in blood and skin but not in semen.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.